- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 209/44 - Iso-indolesHydrogenated iso-indoles
Patent holdings for IPC class C07D 209/44
Total number of patents in this class: 496
10-year publication summary
|
26
|
40
|
27
|
43
|
32
|
37
|
29
|
38
|
25
|
16
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Abbvie Inc. | 1800 |
13 |
| Neophore Limited | 17 |
13 |
| Achillion Pharmaceuticals, Inc. | 164 |
10 |
| AstraZeneca AB | 2909 |
9 |
| Cognition Therapeutics, Inc. | 39 |
8 |
| Orion Corporation | 643 |
7 |
| VALO Health, Inc. | 172 |
7 |
| F. Hoffmann-La Roche AG | 7925 |
6 |
| The General Hospital Corporation | 4733 |
6 |
| Astellas Pharma Inc. | 1088 |
6 |
| Astex Therapeutics Limited | 237 |
6 |
| The Broad Institute, Inc. | 1808 |
6 |
| Mitsubishi Tanabe Pharma Corporation | 579 |
6 |
| Nerviano Medical Sciences S.r.l. | 256 |
6 |
| Taisho Pharmaceutical Co., Ltd. | 870 |
6 |
| Massachusetts Institute of Technology | 10057 |
5 |
| Jiangsu Hengrui Medicine Co., Ltd. | 706 |
5 |
| Shanghai Hengrui Pharmaceutical Co., Ltd. | 644 |
5 |
| The University Court of the University of Aberdeen | 122 |
5 |
| Hoffmann-La Roche Inc. | 3418 |
4 |
| Other owners | 357 |